LPI (LP Information)' newest research report, the “Nano-based Drug Delivery System Industry Forecast” looks at past sales and reviews total world Nano-based Drug Delivery System sales in 2022, providing a comprehensive analysis by region and market sector of projected Nano-based Drug Delivery System sales for 2023 through 2029. With Nano-based Drug Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nano-based Drug Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Nano-based Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nano-based Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nano-based Drug Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nano-based Drug Delivery System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nano-based Drug Delivery System.
The global Nano-based Drug Delivery System market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nano-based Drug Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nano-based Drug Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nano-based Drug Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nano-based Drug Delivery System players cover Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi and Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nano-based Drug Delivery System market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Less than 50nm
50-150nm
150-300nm
Others
Segmentation by application
Hydrophilic Drugs
Hydrophobic Drugs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
This Insight Report provides a comprehensive analysis of the global Nano-based Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nano-based Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nano-based Drug Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nano-based Drug Delivery System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nano-based Drug Delivery System.
The global Nano-based Drug Delivery System market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nano-based Drug Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nano-based Drug Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nano-based Drug Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nano-based Drug Delivery System players cover Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi and Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nano-based Drug Delivery System market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Less than 50nm
50-150nm
150-300nm
Others
Segmentation by application
Hydrophilic Drugs
Hydrophobic Drugs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nano-based Drug Delivery System Market Size 2018-2029
2.1.2 Nano-based Drug Delivery System Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nano-based Drug Delivery System Segment by Type
2.2.1 Less than 50nm
2.2.2 50-150nm
2.2.3 150-300nm
2.2.4 Others
2.3 Nano-based Drug Delivery System Market Size by Type
2.3.1 Nano-based Drug Delivery System Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nano-based Drug Delivery System Market Size Market Share by Type (2018-2023)
2.4 Nano-based Drug Delivery System Segment by Application
2.4.1 Hydrophilic Drugs
2.4.2 Hydrophobic Drugs
2.5 Nano-based Drug Delivery System Market Size by Application
2.5.1 Nano-based Drug Delivery System Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nano-based Drug Delivery System Market Size Market Share by Application (2018-2023)
3 Nano-based Drug Delivery System Market Size by Player
3.1 Nano-based Drug Delivery System Market Size Market Share by Players
3.1.1 Global Nano-based Drug Delivery System Revenue by Players (2018-2023)
3.1.2 Global Nano-based Drug Delivery System Revenue Market Share by Players (2018-2023)
3.2 Global Nano-based Drug Delivery System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nano-based Drug Delivery System by Regions
4.1 Nano-based Drug Delivery System Market Size by Regions (2018-2023)
4.2 Americas Nano-based Drug Delivery System Market Size Growth (2018-2023)
4.3 APAC Nano-based Drug Delivery System Market Size Growth (2018-2023)
4.4 Europe Nano-based Drug Delivery System Market Size Growth (2018-2023)
4.5 Middle East & Africa Nano-based Drug Delivery System Market Size Growth (2018-2023)
5 Americas
5.1 Americas Nano-based Drug Delivery System Market Size by Country (2018-2023)
5.2 Americas Nano-based Drug Delivery System Market Size by Type (2018-2023)
5.3 Americas Nano-based Drug Delivery System Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nano-based Drug Delivery System Market Size by Region (2018-2023)
6.2 APAC Nano-based Drug Delivery System Market Size by Type (2018-2023)
6.3 APAC Nano-based Drug Delivery System Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nano-based Drug Delivery System by Country (2018-2023)
7.2 Europe Nano-based Drug Delivery System Market Size by Type (2018-2023)
7.3 Europe Nano-based Drug Delivery System Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nano-based Drug Delivery System by Region (2018-2023)
8.2 Middle East & Africa Nano-based Drug Delivery System Market Size by Type (2018-2023)
8.3 Middle East & Africa Nano-based Drug Delivery System Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nano-based Drug Delivery System Market Forecast
10.1 Global Nano-based Drug Delivery System Forecast by Regions (2024-2029)
10.1.1 Global Nano-based Drug Delivery System Forecast by Regions (2024-2029)
10.1.2 Americas Nano-based Drug Delivery System Forecast
10.1.3 APAC Nano-based Drug Delivery System Forecast
10.1.4 Europe Nano-based Drug Delivery System Forecast
10.1.5 Middle East & Africa Nano-based Drug Delivery System Forecast
10.2 Americas Nano-based Drug Delivery System Forecast by Country (2024-2029)
10.2.1 United States Nano-based Drug Delivery System Market Forecast
10.2.2 Canada Nano-based Drug Delivery System Market Forecast
10.2.3 Mexico Nano-based Drug Delivery System Market Forecast
10.2.4 Brazil Nano-based Drug Delivery System Market Forecast
10.3 APAC Nano-based Drug Delivery System Forecast by Region (2024-2029)
10.3.1 China Nano-based Drug Delivery System Market Forecast
10.3.2 Japan Nano-based Drug Delivery System Market Forecast
10.3.3 Korea Nano-based Drug Delivery System Market Forecast
10.3.4 Southeast Asia Nano-based Drug Delivery System Market Forecast
10.3.5 India Nano-based Drug Delivery System Market Forecast
10.3.6 Australia Nano-based Drug Delivery System Market Forecast
10.4 Europe Nano-based Drug Delivery System Forecast by Country (2024-2029)
10.4.1 Germany Nano-based Drug Delivery System Market Forecast
10.4.2 France Nano-based Drug Delivery System Market Forecast
10.4.3 UK Nano-based Drug Delivery System Market Forecast
10.4.4 Italy Nano-based Drug Delivery System Market Forecast
10.4.5 Russia Nano-based Drug Delivery System Market Forecast
10.5 Middle East & Africa Nano-based Drug Delivery System Forecast by Region (2024-2029)
10.5.1 Egypt Nano-based Drug Delivery System Market Forecast
10.5.2 South Africa Nano-based Drug Delivery System Market Forecast
10.5.3 Israel Nano-based Drug Delivery System Market Forecast
10.5.4 Turkey Nano-based Drug Delivery System Market Forecast
10.5.5 GCC Countries Nano-based Drug Delivery System Market Forecast
10.6 Global Nano-based Drug Delivery System Forecast by Type (2024-2029)
10.7 Global Nano-based Drug Delivery System Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Nano-based Drug Delivery System Product Offered
11.1.3 Amgen Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Nano-based Drug Delivery System Product Offered
11.2.3 Teva Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Nano-based Drug Delivery System Product Offered
11.3.3 Roche Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Information
11.4.2 UCB (Union Chimique Belge) Nano-based Drug Delivery System Product Offered
11.4.3 UCB (Union Chimique Belge) Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 UCB (Union Chimique Belge) Main Business Overview
11.4.5 UCB (Union Chimique Belge) Latest Developments
11.5 Celgene
11.5.1 Celgene Company Information
11.5.2 Celgene Nano-based Drug Delivery System Product Offered
11.5.3 Celgene Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Celgene Main Business Overview
11.5.5 Celgene Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Nano-based Drug Delivery System Product Offered
11.6.3 Merck Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Information
11.7.2 Gilead Sciences Nano-based Drug Delivery System Product Offered
11.7.3 Gilead Sciences Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Gilead Sciences Main Business Overview
11.7.5 Gilead Sciences Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Nano-based Drug Delivery System Product Offered
11.8.3 Sanofi Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Nano-based Drug Delivery System Product Offered
11.9.3 Pfizer Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Nano-based Drug Delivery System Product Offered
11.10.3 Takeda Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Information
11.11.2 Bausch&Lomb Nano-based Drug Delivery System Product Offered
11.11.3 Bausch&Lomb Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bausch&Lomb Main Business Overview
11.11.5 Bausch&Lomb Latest Developments
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Information
11.12.2 Samyang Biopharmaceuticals Nano-based Drug Delivery System Product Offered
11.12.3 Samyang Biopharmaceuticals Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Samyang Biopharmaceuticals Main Business Overview
11.12.5 Samyang Biopharmaceuticals Latest Developments
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Information
11.13.2 Johnson & Johnson Nano-based Drug Delivery System Product Offered
11.13.3 Johnson & Johnson Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Johnson & Johnson Main Business Overview
11.13.5 Johnson & Johnson Latest Developments
11.14 TOLMAR
11.14.1 TOLMAR Company Information
11.14.2 TOLMAR Nano-based Drug Delivery System Product Offered
11.14.3 TOLMAR Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 TOLMAR Main Business Overview
11.14.5 TOLMAR Latest Developments
11.15 Astellas
11.15.1 Astellas Company Information
11.15.2 Astellas Nano-based Drug Delivery System Product Offered
11.15.3 Astellas Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Astellas Main Business Overview
11.15.5 Astellas Latest Developments
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Information
11.16.2 AMAG Pharmaceuticals Nano-based Drug Delivery System Product Offered
11.16.3 AMAG Pharmaceuticals Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 AMAG Pharmaceuticals Main Business Overview
11.16.5 AMAG Pharmaceuticals Latest Developments
11.17 AbbVie
11.17.1 AbbVie Company Information
11.17.2 AbbVie Nano-based Drug Delivery System Product Offered
11.17.3 AbbVie Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 AbbVie Main Business Overview
11.17.5 AbbVie Latest Developments
11.18 Dr Reddy
11.18.1 Dr Reddy Company Information
11.18.2 Dr Reddy Nano-based Drug Delivery System Product Offered
11.18.3 Dr Reddy Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Dr Reddy Main Business Overview
11.18.5 Dr Reddy Latest Developments
11.19 AstraZeneca
11.19.1 AstraZeneca Company Information
11.19.2 AstraZeneca Nano-based Drug Delivery System Product Offered
11.19.3 AstraZeneca Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 AstraZeneca Main Business Overview
11.19.5 AstraZeneca Latest Developments
11.20 Aspen
11.20.1 Aspen Company Information
11.20.2 Aspen Nano-based Drug Delivery System Product Offered
11.20.3 Aspen Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Aspen Main Business Overview
11.20.5 Aspen Latest Developments
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Information
11.21.2 Acrotech Biopharma Nano-based Drug Delivery System Product Offered
11.21.3 Acrotech Biopharma Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Acrotech Biopharma Main Business Overview
11.21.5 Acrotech Biopharma Latest Developments
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Information
11.22.2 TWi Pharmaceuticals Nano-based Drug Delivery System Product Offered
11.22.3 TWi Pharmaceuticals Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 TWi Pharmaceuticals Main Business Overview
11.22.5 TWi Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nano-based Drug Delivery System Market Size 2018-2029
2.1.2 Nano-based Drug Delivery System Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nano-based Drug Delivery System Segment by Type
2.2.1 Less than 50nm
2.2.2 50-150nm
2.2.3 150-300nm
2.2.4 Others
2.3 Nano-based Drug Delivery System Market Size by Type
2.3.1 Nano-based Drug Delivery System Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nano-based Drug Delivery System Market Size Market Share by Type (2018-2023)
2.4 Nano-based Drug Delivery System Segment by Application
2.4.1 Hydrophilic Drugs
2.4.2 Hydrophobic Drugs
2.5 Nano-based Drug Delivery System Market Size by Application
2.5.1 Nano-based Drug Delivery System Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nano-based Drug Delivery System Market Size Market Share by Application (2018-2023)
3 Nano-based Drug Delivery System Market Size by Player
3.1 Nano-based Drug Delivery System Market Size Market Share by Players
3.1.1 Global Nano-based Drug Delivery System Revenue by Players (2018-2023)
3.1.2 Global Nano-based Drug Delivery System Revenue Market Share by Players (2018-2023)
3.2 Global Nano-based Drug Delivery System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nano-based Drug Delivery System by Regions
4.1 Nano-based Drug Delivery System Market Size by Regions (2018-2023)
4.2 Americas Nano-based Drug Delivery System Market Size Growth (2018-2023)
4.3 APAC Nano-based Drug Delivery System Market Size Growth (2018-2023)
4.4 Europe Nano-based Drug Delivery System Market Size Growth (2018-2023)
4.5 Middle East & Africa Nano-based Drug Delivery System Market Size Growth (2018-2023)
5 Americas
5.1 Americas Nano-based Drug Delivery System Market Size by Country (2018-2023)
5.2 Americas Nano-based Drug Delivery System Market Size by Type (2018-2023)
5.3 Americas Nano-based Drug Delivery System Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nano-based Drug Delivery System Market Size by Region (2018-2023)
6.2 APAC Nano-based Drug Delivery System Market Size by Type (2018-2023)
6.3 APAC Nano-based Drug Delivery System Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nano-based Drug Delivery System by Country (2018-2023)
7.2 Europe Nano-based Drug Delivery System Market Size by Type (2018-2023)
7.3 Europe Nano-based Drug Delivery System Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nano-based Drug Delivery System by Region (2018-2023)
8.2 Middle East & Africa Nano-based Drug Delivery System Market Size by Type (2018-2023)
8.3 Middle East & Africa Nano-based Drug Delivery System Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nano-based Drug Delivery System Market Forecast
10.1 Global Nano-based Drug Delivery System Forecast by Regions (2024-2029)
10.1.1 Global Nano-based Drug Delivery System Forecast by Regions (2024-2029)
10.1.2 Americas Nano-based Drug Delivery System Forecast
10.1.3 APAC Nano-based Drug Delivery System Forecast
10.1.4 Europe Nano-based Drug Delivery System Forecast
10.1.5 Middle East & Africa Nano-based Drug Delivery System Forecast
10.2 Americas Nano-based Drug Delivery System Forecast by Country (2024-2029)
10.2.1 United States Nano-based Drug Delivery System Market Forecast
10.2.2 Canada Nano-based Drug Delivery System Market Forecast
10.2.3 Mexico Nano-based Drug Delivery System Market Forecast
10.2.4 Brazil Nano-based Drug Delivery System Market Forecast
10.3 APAC Nano-based Drug Delivery System Forecast by Region (2024-2029)
10.3.1 China Nano-based Drug Delivery System Market Forecast
10.3.2 Japan Nano-based Drug Delivery System Market Forecast
10.3.3 Korea Nano-based Drug Delivery System Market Forecast
10.3.4 Southeast Asia Nano-based Drug Delivery System Market Forecast
10.3.5 India Nano-based Drug Delivery System Market Forecast
10.3.6 Australia Nano-based Drug Delivery System Market Forecast
10.4 Europe Nano-based Drug Delivery System Forecast by Country (2024-2029)
10.4.1 Germany Nano-based Drug Delivery System Market Forecast
10.4.2 France Nano-based Drug Delivery System Market Forecast
10.4.3 UK Nano-based Drug Delivery System Market Forecast
10.4.4 Italy Nano-based Drug Delivery System Market Forecast
10.4.5 Russia Nano-based Drug Delivery System Market Forecast
10.5 Middle East & Africa Nano-based Drug Delivery System Forecast by Region (2024-2029)
10.5.1 Egypt Nano-based Drug Delivery System Market Forecast
10.5.2 South Africa Nano-based Drug Delivery System Market Forecast
10.5.3 Israel Nano-based Drug Delivery System Market Forecast
10.5.4 Turkey Nano-based Drug Delivery System Market Forecast
10.5.5 GCC Countries Nano-based Drug Delivery System Market Forecast
10.6 Global Nano-based Drug Delivery System Forecast by Type (2024-2029)
10.7 Global Nano-based Drug Delivery System Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Nano-based Drug Delivery System Product Offered
11.1.3 Amgen Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Nano-based Drug Delivery System Product Offered
11.2.3 Teva Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Nano-based Drug Delivery System Product Offered
11.3.3 Roche Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Information
11.4.2 UCB (Union Chimique Belge) Nano-based Drug Delivery System Product Offered
11.4.3 UCB (Union Chimique Belge) Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 UCB (Union Chimique Belge) Main Business Overview
11.4.5 UCB (Union Chimique Belge) Latest Developments
11.5 Celgene
11.5.1 Celgene Company Information
11.5.2 Celgene Nano-based Drug Delivery System Product Offered
11.5.3 Celgene Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Celgene Main Business Overview
11.5.5 Celgene Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Nano-based Drug Delivery System Product Offered
11.6.3 Merck Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Information
11.7.2 Gilead Sciences Nano-based Drug Delivery System Product Offered
11.7.3 Gilead Sciences Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Gilead Sciences Main Business Overview
11.7.5 Gilead Sciences Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Nano-based Drug Delivery System Product Offered
11.8.3 Sanofi Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Nano-based Drug Delivery System Product Offered
11.9.3 Pfizer Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Nano-based Drug Delivery System Product Offered
11.10.3 Takeda Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Information
11.11.2 Bausch&Lomb Nano-based Drug Delivery System Product Offered
11.11.3 Bausch&Lomb Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bausch&Lomb Main Business Overview
11.11.5 Bausch&Lomb Latest Developments
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Information
11.12.2 Samyang Biopharmaceuticals Nano-based Drug Delivery System Product Offered
11.12.3 Samyang Biopharmaceuticals Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Samyang Biopharmaceuticals Main Business Overview
11.12.5 Samyang Biopharmaceuticals Latest Developments
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Information
11.13.2 Johnson & Johnson Nano-based Drug Delivery System Product Offered
11.13.3 Johnson & Johnson Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Johnson & Johnson Main Business Overview
11.13.5 Johnson & Johnson Latest Developments
11.14 TOLMAR
11.14.1 TOLMAR Company Information
11.14.2 TOLMAR Nano-based Drug Delivery System Product Offered
11.14.3 TOLMAR Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 TOLMAR Main Business Overview
11.14.5 TOLMAR Latest Developments
11.15 Astellas
11.15.1 Astellas Company Information
11.15.2 Astellas Nano-based Drug Delivery System Product Offered
11.15.3 Astellas Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Astellas Main Business Overview
11.15.5 Astellas Latest Developments
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Information
11.16.2 AMAG Pharmaceuticals Nano-based Drug Delivery System Product Offered
11.16.3 AMAG Pharmaceuticals Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 AMAG Pharmaceuticals Main Business Overview
11.16.5 AMAG Pharmaceuticals Latest Developments
11.17 AbbVie
11.17.1 AbbVie Company Information
11.17.2 AbbVie Nano-based Drug Delivery System Product Offered
11.17.3 AbbVie Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 AbbVie Main Business Overview
11.17.5 AbbVie Latest Developments
11.18 Dr Reddy
11.18.1 Dr Reddy Company Information
11.18.2 Dr Reddy Nano-based Drug Delivery System Product Offered
11.18.3 Dr Reddy Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Dr Reddy Main Business Overview
11.18.5 Dr Reddy Latest Developments
11.19 AstraZeneca
11.19.1 AstraZeneca Company Information
11.19.2 AstraZeneca Nano-based Drug Delivery System Product Offered
11.19.3 AstraZeneca Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 AstraZeneca Main Business Overview
11.19.5 AstraZeneca Latest Developments
11.20 Aspen
11.20.1 Aspen Company Information
11.20.2 Aspen Nano-based Drug Delivery System Product Offered
11.20.3 Aspen Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Aspen Main Business Overview
11.20.5 Aspen Latest Developments
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Information
11.21.2 Acrotech Biopharma Nano-based Drug Delivery System Product Offered
11.21.3 Acrotech Biopharma Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Acrotech Biopharma Main Business Overview
11.21.5 Acrotech Biopharma Latest Developments
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Information
11.22.2 TWi Pharmaceuticals Nano-based Drug Delivery System Product Offered
11.22.3 TWi Pharmaceuticals Nano-based Drug Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 TWi Pharmaceuticals Main Business Overview
11.22.5 TWi Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.